Bone mineral density changes after parathyroidectomy are dependent on biochemical profile

Area of Science:

• Endocrinology
• Bone Metabolism
• Surgical Outcomes

Background:

• Primary hyperparathyroidism (PHPT) is often associated with decreased bone mineral density (BMD).
• Parathyroidectomy (PTX) is a common treatment for PHPT, with known benefits for BMD in hypercalcemic patients.
• Limited data exist on PTX effects on BMD in normocalcemic and normohormonal PHPT.

Purpose of the Study:

• To investigate the impact of PTX on BMD in patients with primary hyperparathyroidism, specifically comparing outcomes based on biochemical profiles.
• To determine if normocalcemic and normohormonal PHPT patients experience similar skeletal benefits post-PTX as typical PHPT patients.

Main Methods:

• Retrospective analysis of 92 PHPT patients undergoing PTX (2004-2012).
• Pre- and post-operative BMD measurements using dual-energy x-ray absorptiometry (DXA).
• Log linear mixed models used to analyze within-person BMD changes, stratified by biochemical status (typical, normocalcemic, normohormonal).

Main Results:

• Overall cohort showed increased BMD post-PTX at lumbar spine (+2.5%), femoral neck (+2.1%), and total hip (+1.9%), with a decrease at the one-third radius (-0.9%).
• Patients with typical PHPT profile demonstrated significant BMD increases at lumbar spine, femoral neck, and total hip.
• Normohormonal group showed BMD improvement only at the femoral neck, while normocalcemic group had no significant BMD changes at any site.

Conclusions:

• The skeletal benefits of PTX are attenuated in patients with normocalcemic and normohormonal primary hyperparathyroidism.
• Biochemical profile significantly influences BMD response to PTX in PHPT patients.
• PTX outcomes regarding bone health are dependent on the patient's specific biochemical characteristics.